Hepatitis E virus in wild and domestic rabbits from Portugal: a combined molecular and longitudinal serological study
Veterinary Research Communications · 2024
DOI: 10.1007/s11259-024-10452-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Research Communications, 2024. Verfasst von Sérgio Santos-Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Hepatitis E virus, Hepatitis E, Animals, Wild. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade do Porto.
Abstract (Originalsprache)
Hepatitis E virus (HEV), species Paslahepevirus balayani , poses a global public health threat, especially in developing countries, by causing acute enterically transmitted hepatitis. HEV infects various mammalian hosts and belongs to the genus Paslahepevirus in the family Hepeviridae . While swine are recognized as the main hosts of HEV, rabbits, which can also be affected by swine HEV-3 related strains, serve as the primary reservoir for the distinct emerging and zoonotic HEV-3ra subtype. In Portugal, where the European wild rabbit is abundant, their role in HEV epidemiology remains unclear. The primary aim of the present research was to evaluate the circulation and the potential for HEV infection within these species. This study employed a molecular and longitudinal serological approach to investigate HEV in Portuguese rabbits. Among the 205 wild rabbits tested, a seroprevalence of 2.44% (95% CI: 0.80–5.60) was found, with no significant associations with age, sex, localization, or sampling dates. Seropositive animals were found in the south and center regions of the country. HEV RNA was not detected in 120 fecal samples, suggesting a natural, low level, and widespread viral circulation. The study underscores the need for further research to comprehend HEV dynamics in these species, which is crucial for assessing potential transmission risks to humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.
- CIBIO/InBio, Research Center in Biodiversity and Genetic Resources, Campus of Vairão, University of Porto, Vila do Conde, Portugal.
- Unit of Infectious Diseases, Hospital Universitario Reina Sofia, Clinical Virology and Zoonoses, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.
- Center for Biomedical Research Network (CIBER) in Infectious Diseases, Health Institute Carlos III, Madrid, Spain.
- Faculty of Pharmacy, University of Porto (FFUP), Porto, Portugal.
- LAQV, REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.
Förderung
- Universidade do Porto
Zitieren
APA
Santos-Silva, S., Santos, N., López-López, P., Nascimento, M. S. J., Gonçalves, H. M. R., Van der Poel, W. H. M., Rivero-Juarez, A., & Mesquita, J. R. (2024). Hepatitis E virus in wild and domestic rabbits from Portugal: a combined molecular and longitudinal serological study. Veterinary Research Communications. https://doi.org/10.1007/s11259-024-10452-7
Vancouver
Santos-Silva S, Santos N, López-López P, Nascimento MSJ, Gonçalves HMR, Van der Poel WHM, et al. Hepatitis E virus in wild and domestic rabbits from Portugal: a combined molecular and longitudinal serological study. Veterinary Research Communications. 2024. doi:10.1007/s11259-024-10452-7
BibTeX
@article{SantosSilva2024,
author = {Santos-Silva, Sérgio and Santos, Nuno and López-López, Pedro and Nascimento, Maria S J and Gonçalves, Helena M R and Van der Poel, Wim H M and Rivero-Juarez, António and Mesquita, João R},
title = {Hepatitis E virus in wild and domestic rabbits from Portugal: a combined molecular and longitudinal serological study},
journal = {Veterinary Research Communications},
year = {2024},
doi = {10.1007/s11259-024-10452-7}
}
EUVIMED